L. Scopece

951 total citations
18 papers, 750 citations indexed

About

L. Scopece is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, L. Scopece has authored 18 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Genetics, 11 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in L. Scopece's work include Glioma Diagnosis and Treatment (15 papers), Brain Metastases and Treatment (9 papers) and Cancer Treatment and Pharmacology (4 papers). L. Scopece is often cited by papers focused on Glioma Diagnosis and Treatment (15 papers), Brain Metastases and Treatment (9 papers) and Cancer Treatment and Pharmacology (4 papers). L. Scopece collaborates with scholars based in Italy, United Kingdom and India. L. Scopece's co-authors include Enrico Franceschi, Alba A. Brandes, Mario Ermani, Alicia Tosoni, Lucio Crinò, Giovanni Cavallo, R. Agati, A. Tosoni, Francesca Benevento and A. Bacci and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer.

In The Last Decade

L. Scopece

18 papers receiving 738 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Scopece Italy 10 539 360 240 157 139 18 750
Debra C. LaFrankie United States 10 537 1.0× 201 0.6× 200 0.8× 180 1.1× 98 0.7× 19 701
T. Mikkelsen United States 11 515 1.0× 220 0.6× 270 1.1× 205 1.3× 71 0.5× 21 731
Marina Faedi Italy 13 412 0.8× 213 0.6× 157 0.7× 164 1.0× 117 0.8× 27 710
Michael Prados United States 15 522 1.0× 206 0.6× 226 0.9× 105 0.7× 141 1.0× 39 794
Shannon Chang United States 14 635 1.2× 248 0.7× 281 1.2× 208 1.3× 110 0.8× 37 928
J. Norfleet United States 7 496 0.9× 179 0.5× 212 0.9× 210 1.3× 217 1.6× 11 752
Walter Curran United States 5 738 1.4× 404 1.1× 158 0.7× 195 1.2× 178 1.3× 8 940
Emese Filka United States 6 533 1.0× 202 0.6× 240 1.0× 197 1.3× 57 0.4× 9 672
Gaspar Reynés Spain 14 472 0.9× 219 0.6× 371 1.5× 232 1.5× 106 0.8× 40 898
Tim Cloughesy United States 9 431 0.8× 176 0.5× 267 1.1× 142 0.9× 71 0.5× 17 758

Countries citing papers authored by L. Scopece

Since Specialization
Citations

This map shows the geographic impact of L. Scopece's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Scopece with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Scopece more than expected).

Fields of papers citing papers by L. Scopece

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Scopece. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Scopece. The network helps show where L. Scopece may publish in the future.

Co-authorship network of co-authors of L. Scopece

This figure shows the co-authorship network connecting the top 25 collaborators of L. Scopece. A scholar is included among the top collaborators of L. Scopece based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Scopece. L. Scopece is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Franceschi, Enrico, A. Tosoni, Stefania Bartolini, et al.. (2011). Prognostic factors in newly diagnosed glioblastoma: Have we missed gender?. Journal of Clinical Oncology. 29(15_suppl). 2058–2058. 2 indexed citations
2.
Franceschi, Enrico, A. Tosoni, R. Agati, et al.. (2010). Efficacy of tailored treatment for high- and low-risk medulloblastoma in adults: A large prospective phase II trial.. Journal of Clinical Oncology. 28(15_suppl). 2003–2003. 10 indexed citations
3.
Brandes, Alba A., Enrico Franceschi, Alicia Tosoni, et al.. (2009). Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma. Cancer. 115(15). 3512–3518. 181 indexed citations
4.
Franceschi, Enrico, Giovanni Cavallo, Sara Lonardi, et al.. (2007). Gefitinib in patients with progressive high-grade gliomas: a multicentre phase II study by Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). British Journal of Cancer. 96(7). 1047–1051. 163 indexed citations
5.
Franceschi, Enrico, A. Tosoni, V. Blatt, et al.. (2007). 2518 POSTER Prolonged maintenance chemotherapy with Temozolomide (TMZ) after concomitant treatment in newly diagnosed GBM: safety profile. European Journal of Cancer Supplements. 5(4). 232–233. 1 indexed citations
6.
Scopece, L., Enrico Franceschi, Giovanna Cavallo, et al.. (2006). Carboplatin and etoposide (CE) chemotherapy in patients with recurrent or progressive oligodendroglial tumors. Journal of Neuro-Oncology. 79(3). 299–305. 8 indexed citations
7.
Tosoni, A., Giovanni Cavallo, Mario Ermani, et al.. (2006). Is protracted low-dose temozolomide feasible in glioma patients?. Neurology. 66(3). 427–429. 33 indexed citations
8.
Brandes, Alba A., A. Tosoni, Giovanni Cavallo, et al.. (2006). Temozolomide (TMZ) 3 weeks on/1 week off in the treatment of progressive low grade gliomas: A phase II GICNO study. Journal of Clinical Oncology. 24(18_suppl). 1514–1514. 4 indexed citations
9.
Franceschi, Enrico, L. Scopece, Stefania Gori, Rita Chiari, & Lucio Crinò. (2006). Primary and metastatic brain tumors.. PubMed. 14(1). E2–E2. 1 indexed citations
10.
Franceschi, Enrico, Giovanna Cavallo, L. Scopece, et al.. (2005). Temozolomide-induced partial response in a patient with primary diffuse leptomeningeal gliomatosis. Journal of Neuro-Oncology. 73(3). 261–264. 30 indexed citations
11.
Brandes, Alba A., Giovanna Cavallo, Michele Reni, et al.. (2005). A multicenter retrospective study of chemotherapy for recurrent intracranial ependymal tumors in adults by the Gruppo Italiano Cooperativo di Neuro‐Oncologia. Cancer. 104(1). 143–148. 55 indexed citations
12.
Franceschi, Enrico, Sara Lonardi, A. Tosoni, et al.. (2005). Gefitinib (ZD1839) treatment for adult patients with progressive high-grade gliomas (HGG): An open label, single-arm, phase II study of the Gruppo Italiano Cooperativo di Neuro-Oncologia (GICNO). Journal of Clinical Oncology. 23(16_suppl). 1564–1564. 6 indexed citations
13.
Brandes, Alba A., Giovanni Cavallo, A. Tosoni, et al.. (2005). Temozolomide (TMZ) for progressive primitive brain tumors: safety at 75 mg/m2 a day for 21 days every 28: A GICNO (Italian Neuro-Oncology Group) study. Journal of Clinical Oncology. 23(16_suppl). 1541–1541. 1 indexed citations
14.
Franceschi, Enrico, Giovanni Cavallo, L. Scopece, et al.. (2004). Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma. British Journal of Cancer. 91(6). 1038–1044. 41 indexed citations
15.
Brandes, Alba A., Umberto Basso, Michele Reni, et al.. (2004). First-Line Chemotherapy With Cisplatin Plus Fractionated Temozolomide in Recurrent Glioblastoma Multiforme: A Phase II Study of the Gruppo Italiano Cooperativo di Neuro-Oncologia. Journal of Clinical Oncology. 22(9). 1598–1604. 93 indexed citations
16.
Crinò, Lucio, Enrico Franceschi, & L. Scopece. (2002). HER-2 Inhibitors: Clinical Results. Tumori Journal. 1(6_suppl1). S3–S4. 2 indexed citations
17.
Astolfi, Annalisa, Carla De Giovanni, Lorena Landuzzi, et al.. (2001). Identification of new genes related to the myogenic differentiation arrest of human rhabdomyosarcoma cells. Gene. 274(1-2). 139–149. 43 indexed citations
18.
Landuzzi, Lorena, Carla De Giovanni, Giordano Nicoletti, et al.. (2000). The Metastatic Ability of Ewing's Sarcoma Cells Is Modulated by Stem Cell Factor and by Its Receptor c-kit. American Journal Of Pathology. 157(6). 2123–2131. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Debra C. LaFrankie Breakdown of academic impact, for papers by T. Mikkelsen Breakdown of academic impact, for papers by Marina Faedi Breakdown of academic impact, for papers by Michael Prados Breakdown of academic impact, for papers by Shannon Chang Breakdown of academic impact, for papers by J. Norfleet Breakdown of academic impact, for papers by Walter Curran Breakdown of academic impact, for papers by Emese Filka Breakdown of academic impact, for papers by Gaspar Reynés Breakdown of academic impact, for papers by Tim Cloughesy
Rankless by CCL
2026